FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a biologically active substance possessing the antiaggregant properties. The technical effect: what is produced is a drug preparation of a new compound of (2E)-3-[1-(2-hydroxy-3-piperidin-1-ylpropyl)-1 H-indol-3-yl]-1-(2-thienyl)prop-2-en-1-one hydrochloride of formula I possessing antiaggregant action:
.
EFFECT: substance may be used in medicine for producing a drug preparation for preventing the conditions associated with a high thrombogenic potential of blood.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
HYDROHALOGENIDES 3-[1-(2-HYDROXY-3-PIPERIDINE-1-YL-PROPYL)-1H-INDOLE-3-YL]-1-PHENYL-PROPENONE, HAVING LOCAL ANAESTHETISING AND ANTI-ARRHYTHMIC ACTIVITY | 2008 |
|
RU2408592C2 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
1-SUBSTITUTED-3-{[2-(3,5-DI-TRET-4-HYDROXYPHENYL)-2-OXOETHYL]}-2AMINOBENZIMIDAZOLIUM BROMIDES WITH ANTIPLATELET AND ANTIOXIDANT PROPERTIES | 2016 |
|
RU2623439C1 |
AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
2-(2-OXOINDOLIN-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YLPROPYL)-6,7-DIHYDRO-1-H-PYRROLE[3,2-C]PYRIDIN-4(5H)-ONE COMPOUNDS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2008 |
|
RU2472792C2 |
AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
USE OF 2,3,4-TRIMETHOXY-5-HYDROXY-9,10-DIHYDROPHENANTHRENE AS AN AGENT WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2808460C1 |
5-(4'-HYDROXYPHENYL)-AND 5-(2',5'-DIHYDROXYPHENYL)-6 H-1,3,4-THIADIAZINE-2-AMINES, HYDROHALOGENIDES INHIBITING THROMBOCYTE AGGREGATION IN INTRAVENOUS INTRODUCTION | 2009 |
|
RU2458060C2 |
N-[(1H-PYRAZOL-1-YL) ARYL]-1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES, PRODUCING AND USING THEM AS P2Y12 ANTAGONISTS | 2011 |
|
RU2572593C2 |
Authors
Dates
2013-06-27—Published
2011-07-28—Filed